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j ourna l homepage: www.e lsev ie r .com/ locate /atgOmics challenges and unmet translational needsClearly, high throughput omics, and related technologies, are ad-
vancing quickly. So too are the many challenges to efﬁcient analysis
and interpretation of data generated. This issue presents cutting edge
research and unmet translational needs related to these challenges.
Marcus, et al., address the scarcity of standardized sequencing proce-
dures, data formats and quality management in ‘Standardization and
quality management in next-generation sequencing. They present cur-
rent standardization and quality management efforts in documentation
and guidelines for validating sequencing workﬂows as well as
the development and implementation of quality metrics for upstream
processes and downstreampipeline datamanagement. These standard-
ization issues must be addressed to ensure reliable results and fast pro-
cessing required for next-generation based clinical diagnostics. Chia, et.
al. outline the need for multi-omics data integration and accompanying
challenges’. In ‘Metabolic modeling with big data and the gut
microbiome’, they present current limitations to capturing the full po-
tential of omics-based approaches. Calling for a new paradigm for met-
abolic modeling, Chia et al., offer a framework for characterizing the
ecology of the gut microbiome based on a model of metabolic network-
ing. Maher, et al. also address the challenges in understanding complex
omics data. They report on the recent Keystone Symposium, ‘Human
nutrition, environment and health’, the ﬁrst-of-its-kind global meeting
on state of the art research in nutritional science, with a focus on per-
sonalized nutrition. The main topics were 1) the interaction betweenhttp://dx.doi.org/10.1016/j.atg.2016.08.002
2212-0661/© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NChuman genome, diet and environment; 2) translational models for
human nutrition; 3) human nutritional and lifestyle interventions;
4) capturing and monitoring human individuality; 5) nutrigenomics
and systems nutrition; 6) Nutrition 2.0 - translational into solution for
human health; and 7) global nutrition and sustainability. Finally,
Messner et al., present results from the ﬁrst two rounds of a four
round Delphi policy study of 48 multi-stakeholder experts on the im-
portance and tractability of 28 potential barriers to clinical adoption of
next-generation sequencing in three major policy domains: 1) intellec-
tual property, coverage and reimbursement and FDA regulation. Not
surprisingly overall results indicate a perceived need for policies to pro-
mote data-sharing and consistent payer coverage policies. Major ﬁnd-
ings are that 1) proprietary variant databases represent a formidable
challenge to adoption; 2) payer policies are a frequent barrier, in part
due to inconsistent coverage policies and; 3) FDA regulation was not
perceived as a formidable barrier.
Together these articles propose next stage tasks to harnessing the
power of omics technologies.
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